No.15

acos9015

Abdullah Murdani

Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine University of Indonesia, Dr. Cipto Mangunkusumo Hospital, Indonesia

A Population-Based Survey on Knowledge and Attitude toward Colorectal Cancer and Colorectal Cancer Screening Among Indonesian Population

No.22

acos9022

Bui Thu Thao L. P.

Ho Chi Minh city Oncology Hospital, Viet Nam

Concurrent Chemoradiotherapy in Locally Advanced stage Tonsillar Carcinoma: Initial Response and Acute Toxicities

No.29

acos9029

Tran Tuong, Thi Anh

Department of Head&Neck Surgery, HoChiMinh city Oncology Hospital,Vietnam

local flaps in reconstruction for skin cancer of the cheek

No.34

acos9034

SRIDEVI VELUSWAMI

DIVISION OF SURGICAL ONCOLOGY, CANCER INSTITUTE (WIA), CHENNAI, INDIA

HEREDITARY BREAST &/or OVARIAN CANCERS IN INDIAN WOMEN

No.39

acos9039

Wang Sophie, S.W.

Division of gastroenterology, department of internal medicine, Kaohsiung Medical University Hospital, Taiwan

Gastrointestinal tumor-derived mesenchymal stem cells are similar to non-tumor-derived mesenchymal stem cells

No.45

acos9045

Takata Ryo

Deparment of Urology, Iwate Medical University, Japan

Genome-wide association study identifies five new susceptibility loci for prostate cancer in Japanese population

No.61

acos9061

LAM DUC HOANG

RADIOTHERAPY OF HEAD AND NECK CANCER DEPARTMENT, CANCER HOSPITAL OF HO CHI MINH CITY, VIET NAM

THE ROLE OF INDUCTION CHEMOTHERAPY IN TREATMENT OF LOCAL REGIONAL ADVANCED TONSILLAR CARCINOMA

No.80

acos9080

SEENIVASAGAM RAJKUMAR K

Department of General Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India"

Surgical Management Of Giant Recurrent Abdominal Wall Desmoid Tumours ? A Case Report and Review of Literature

No.87

acos9087

Tomimaru Yoshito

Department of Surgery, Graduate School of Medicine, Osaka University

IGFBP 7 alters the sensitivity to IFN-based combination therapy in hepatocellular carcinoma cells

No.93

acos9093

Yokoyama Shozo

Second Department of Surgery, Wakayama Medical University, School of Medicine

CEACAM1 and CD133 expressing Spheroid with hollow at the invasion front of colorectal cancer -Novel metastatic and tumor initiating phenotype-.

No.98

acos9098

Ieda Junji

Second Department of Surgery, Wakayama Medical University, Japan

Dominance of CEACAM1 long cytoplasmic isoform is an independent risk factor for metastasis and the short survival of patients with colorectal cancer

No.101

acos9101

Shrestha Sudip

Department of Oncology, Om Hospital and Research Center, Nepal

Safety and efficacy of Gefitinib monotherapy in patients with advanced non-small cell lung cancer (NSCLC): A single institution study (Nepal).

No.103

acos9103

Umemura Shigeki

Department of clinical oncology, Sumitomo-Besshi Hospital Cancer Center, Japan

A randomized phase III study of a cisplatin (CDDP) and docetaxel (DOC) with or without irinotecan (CPT) in patients (pts) with advanced NSCLC: Results of Okayama Lung Cancer Study Group OLCSG 0403

No.113

acos9113

Hasegawa Shinichi

Department of Surgery, Kanagawa Ashigara-kami Hospital

Adenocarcinoma of the Esophagogastric junction at a Japanese High-Volume Cancer Center

No.120

acos9120

Tsuji Toshiaki

2nd Department of Surgery, , School of MedicineWakayama Medical University, Japan

Thrombospondin-1 Expression Enhances Antitumoral Efficacy of Oncolytic Herpes Simplex for Gastric Cancer

No.151

acos9151

Mizukami Yusuke

Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical College

Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduced hypoxia in tumors

No.152

acos9152

Kashiwagi Shinichiro

Department of Surgical Oncology, Osaka City University Graduate School of Medicine

E-cadherin and Ki67 might be a predictive marker for chemo-sensitivity in triple-negative breast cancer

No.180

acos9180

Yoo Changhoon

Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemotherapy in Patients with Breast Cancer

No.197

acos9197

Mitsuhashi Atsushi

Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School, Japan

Novel Therapeutic Strategy with E7080, an Orally Active Inhibitor of Multiple Receptor Tyrosine Kinases, for Controlling Experimental Metastasis by Lung Cancer Cells in Immunodeficient Mice

No.203

acos9203

Kawano Kouichiro

Department of Obstetrics and Gynecology, Kurume University, Japan

Clinicopathological predictive factors of persistence or recurrence after conization for cervical intraepithelial neoplasia

No.205

acos9205

Kim Hyang K

Devison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Collegy of Medicine, Seoul, Korea

Temsirolimus induced non-infectious pneumonitis in metastatic renal cell carcinoma

No.216

acos216

Tokuda Yoshiyuki

Tsuyama Chuo Hospital

A randomized phase III trial comparing docetaxel and cisplatin combination chemotherapy to mitomycin, vindesine and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer: OLCSG 0007

No.224

acos9224

SEENIVASAGAM RAJKUMAR K

Department of General Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Analysis of risk factors for postoperative wound complications in 338 breast cancer patients

No.236

acos9236

Saito Yu

Department of Surgery, The University of Tokushima, Japan

The correlation between cancer stem like cells and epigenetic alteration in intrahepatic cholangiocarcinoma

No.247

acos9247

Inoue Tatsuya

Department of Thoracic Surgery and Oncology, Tokyo Medical University, Japan

Outcomes of airway stenting for advanced lung cancer with central airway

No.273

acos9273

Amatya Kapendra Shekhar

Bhaktapur Cancer Hospital, Kathmandu, Nepal

Conservation Surgery of Breast Cancer at Bhaktapur Cancer Hospital, Nepal

No.276

acos9276

Lakhey Paleswan Joshi

Department of surgery, Tribhuvan University Teaching Hospital, Kathmandu, Nepal

Outcome of Pancreaticoduodenectomy in Tribhuvan University Teaching Hospital, Kathmandu Nepal.

No.277

acos9277

Bhandari Ramesh Singh

Department of surgery, Tribhuvan University Teaching Hospital, Kathmandu, Nepal

Managing Colorectal Cancer: Three Years Review.

No.286

acos9286

Kandel Bishnu P

Department of Surgery, Tribhuban University Teaching Hospital, Nepal

Gastric Cancer Perforation: Report of 22 Cases

No.302

acos9302

Kubota Yasuaki

Department of Urology, TOYOTA Memorial Hospital, Aichi, Japan

Relationship Between Prostate-specific Antigen and Obesity: Analysis of a large cohort of TOYOTA Motor Corporation employees

No.320

acos9320

Kim Hyang K

Division of Medical Oncology, Department of Internal Medicin, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea

Novel sunitinib strategy in metastatic renal cell cancer with hemodialysis

No.337

acos9337

Komatsu Shuhei

Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine

Clinical Evaluation of JCGC and TNM Staging on Multidetector-row Computed Tomography in Preoperative Nodal Staging of Gastric Cancer

No.354

acos9354

Neupane Prakash R.

Department of Surgical Oncology,Bhaktapur Cancer Hospital,Nepal

Carcinoma of Urinary Bladder treated with Radical Cystectomy in Nepal

No.379

acos9379

Lee Young Joo

Center for Clinical Trial, National Cancer Center

Survival determinants in patients with gefitinib-sensitive non-small cell lung cancer; is timing of gefitinib important?

No.414

acos9414

Yoon Dok Hyun

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

FDG-PET as a potential tool to select patients with advanced non-small cell lung cancer (NSCLC) who may spare immediate maintenance therapy after first-line chemotherapy

No.429

acos9429

Nakatsumi Hiroshi

Department of Gastroenterology, Hokkaido University School of Medicine, Japan

The optimal dose period of indisetron tablets for preventing chemotherapy-induced nausea and vomiting (CINV) induced by mFOLFOX6: an exploratory trial ?HGCSG0703-

No.454

acos9454

Ghimire Sarita

Department of gynaecology oncolgy,Bhaktapur Cancer Hospital,Bhaktapur

Clinicopathological factors indicating pelvic lymph nodes metastasis in early stage cervical carcinoma

No.469

acos9469

Lan Keng-Li

Cancer Cancer, Taipei Veterans General Hospital, Taiwan

EGF-conjugated liposomal doxorubicin for treatment of EGFR-overexpressing cancer

No.490

acos9490

Ghimire Bikal

Tribhuvan University Teaching Hospital, Institute of Medicine

Surgical management of Gastric cancer in young adults

Young Investigator’s Award